Shelia Chapman
Nurse Practitioner · Las Vegas, NVNPI 1265939078
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 92.9% of the total across 228 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 31 manufacturers reported payments, led by AbbVie at 33.6% of the total. Reporting peaked in 2021 at $1,193 and has fallen 53.8% since, to $552 in 2025. Among nurse practitioner clinicians in NV with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 228 payments — averaging $21.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Astellas Pharma US Inc$754
- Daiichi Sankyo Inc.$500
- Mayne Pharma Commercial LLC$484
- Exeltis, USA Inc.$232
- Hologic Sales And Service, LLC$221
- plus $1K from 25 others
What the payments were for
- Food & beverage$4,65693%
- Education$3577%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 86 | $1,686 |
| Astellas Pharma US Inc | 25 | $754 |
| Daiichi Sankyo Inc. | 30 | $500 |
| Mayne Pharma Commercial LLC | 10 | $484 |
| Exeltis, USA Inc. | 12 | $232 |
| Hologic Sales And Service, LLC | 10 | $221 |
| Galderma Laboratories, L.p. | 5 | $169 |
| Pfizer | 8 | $163 |
| Therapeuticsmd, Inc. | 7 | $122 |
| Sumitomo Pharma America, Inc. | 1 | $68 |
| Novo Nordisk | 3 | $67 |
| Evofem Biosciences, Inc. | 3 | $65 |
| Sage Therapeutics, LLC | 4 | $62 |
| Optumhealth Care Solutions, LLC | 2 | $61 |
| Bayer | 4 | $56 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $42 |
| Avion Pharmaceuticals | 2 | $29 |
| Amgen | 1 | $22 |
| Corcept Therapeutics | 1 | $22 |
| Merck | 1 | $18 |
| BD | 1 | $18 |
| Pacira Pharmaceuticals Incorporated | 1 | $18 |
| Boston Scientific | 1 | $18 |
| Gynesonics, Inc. | 1 | $17 |
| Intuitive Surgical | 1 | $16 |
| Olympus America Inc. | 1 | $15 |
| Agile Therapeutics, Inc. | 1 | $14 |
| Exact Sciences | 1 | $14 |
| Microline Surgical Inc | 1 | $14 |
| Organon | 1 | $13 |
| Scynexis, Inc. | 1 | $12 |
How this compares
$5,013 in reported general payments places this provider in the 90th percentile of 933 nurse practitioner providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ProgesteroneProgesterone, Micronized | 13 | $930 |
| Estradiol | 18 | $613 |
| Medroxyprogesterone Acetate | 15 | $199 |
| Clobetasol Propionate | 15 | $66 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Las Vegas
- Melanie SpeedLas Vegas$80K
- Shelley MilesLas Vegas$34K
- Nasslynne LenzLas Vegas$32K
- Shannon SouthwickLas Vegas$32K
- Bonnie KwanLas Vegas$30K
- Amanda RalphLas Vegas$26K
- Teodoro AgtayLas Vegas$25K
- Katherine WhitmireLas Vegas$18K
- Jennifer WalshLas Vegas$18K
- Andrew VolinLas Vegas$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.